Mesoblast Ltd - MSB share price
About
Mesoblast Limited, an Australian-based company, focuses on developing late-stage product candidates using proprietary mesenchymal lineage cell therapy platforms. Their flagship products, Remestemcel-L and Rexlemestrocel-L, are in late-stage development for treating various systemic inflammatory diseases and chronic conditions such as acute Graft versus Host Disease, respiratory distress syndrome, chronic heart failure, and low back pain due to degenerative disc disease. Additionally, Mesoblast has commercialized two products in Japan and Europe and established partnerships for Phase III assets in Europe and China.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Price Chart
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Grab Your FREE Report on Top 5 ASX Stocks to Buy in 2026
Latest Article
